RxDoctor Payments Data

Ali Damavandy, MD

MOHS-Micrographic Surgery · Mc Lean, VANPI 1376836668

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 34.0% of the total. Reporting peaked in 2019 at $524 and has fallen 88.4% since, to $61 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in VA, where the typical reported total is $1,276.

$1,276in general payments, 2019–2025

Across 24 payments — averaging $53.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$433
  • UCB, Inc.$248
  • Bristol Myers Squibb$124
  • Novartis$124
  • Janssen Scientific Affairs, LLC$103
  • Sanofi$75
  • plus $169 from 5 others

What the payments were for

  • Food & beverage$1,26499%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,276 in reported general payments places this provider in the 50th percentile of 36 mohs-micrographic surgery providers in Virginia.

See all mohs-micrographic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$693,495
Medicare patients
523
Services billed
2,990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin211$2,063
Clobetasol Propionate26$1,779
Ketoconazole42$888
Halobetasol Propionate16$677
Gentamicin Sulfate12$390
Triamcinolone Acetonide23$330
Cephalexin38$204
Mometasone Furoate14$157
Hydrocortisone22$134

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Mc Lean

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →